Health data company Innovaccer scooped up $150 million in Series E funding, bumping the company’s valuation to $3.2 billion.
The round, which follows a $105 million Series D from February this year, was led by Mubadala Capital, with participation from B Capital Group, Microsoft’s M12 fund, OMERS Growth Equity, Dragoneer, Steadview Capital, Tiger Global Management, Whale Rock Capital Management,...
